Frailty is recognized as a state of age-related decreased resistance and increased vulnerability to adverse outcomes. [1] [2] [3] An increase in recently conducted research on frailty has added mounting evidence to the literature. However, most of the studies focused on non-institutionalized populations and only limited evidence among nursing home (NH) populations exists. As expected, most of the NH patients are very frail. 4 Another common condition among NH populations is vitamin D deficiency. 5 A number of studies have shown associations of vitamin D deficiency with a wide range of skeletal and non-skeletal medical conditions, 6 all of which may contribute to the development of frailty. This study aimed to investigate the association between frailty and vitamin D status among NH patients, which, to our knowledge, has not been examined.
vitamin D deficiency (OR=4.06 , p=0.01) and lower 25(OH)D (OR=0.95 per 1ng/mL increase, p=0.05) were significantly associated with frailty.
DISCUSSION
There has been plausible evidence that supports physiological pathways through which low vitamin D status increases risk of frailty. Low vitamin D levels are associated with poor physical performance 2, 8 and symptoms of depression. 9 Vitamin D has also been found to be involved in inflammatory processes. 10 All of these may contribute to developing and worsening frailty.
Our results should be interpreted with caution. The findings may not be generalizable due to the relatively small cohort consisting of only male veterans. Approximately half of patients were excluded due to vitamin D supplement use (n=109, 36.1%) and 25(OH)D not measured within 7 days of admission (n=61, 20.2%). Excluded patients were older (76.4 vs. 70.3 years, p<0.001), had more ADL disabilities (4.0 vs. 3.1, p<0.001), higher FI (0.42 vs. 0.37, p=0.003), and higher BMI (27.3 vs. 25.1, p=0.005). We also lack data regarding sunlight exposure, which may affect serum 25(OH)D levels. Lastly causal relationship cannot be inferred because of the cross-sectional study design.
However, this study has many strengths. First, this is the first study to report on the associations between frailty and vitamin D among NH patients. Second, this study is especially valuable in that the data were collected at the time of NH admission, not at a certain point during NH stay as in most studies. Third, we excluded vitamin D supplement users to reduced bias. The supplement users (n=109) were significantly older (mean age=77.9 vs. 70.3 years old, p<0.001) and frailer (mean Frailty Index=0.42 vs. 0.37, p=0.003), but had higher mean 25(OH)D level (27.1 ng/mL vs. 21.5 ng/mL, p<0.001). This suggests older frailer NH patients may have already been started on supplementation and thus had higher vitamin D levels. Furthermore, the dosage of the supplementation varied greatly from 400 IU daily to as high as 50,000 IU weekly. Vitamin D supplementation would, if not controlled for, significantly confound the results and lead to misinterpretation.
This study showed the prevalence of frailty was high at 81.6%, and lower vitamin D status was significantly associated with frailty among NH patients. Vitamin D supplementation may potentially be an inexpensive and well-tolerated intervention to prevent or reverse frailty.
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